Health
COVID-19 vaccine | UK reserves 190 million doses from Valneva – Moneycontrol
Valneva said it expects to begin trials of the two-dose vaccine in December and if it is successful for it to become available in the second half of 2021.
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from French-Austrian biotech company Valneva, AFP reported.
The deal between the UK and Valnevaworth as much as 1.37 billion euros, the firm said on September 14.
It had already been disclosed in July that the British government had reserved 60 million doses of Valneva’s inactivated SARS-CoV-2 vaccine under development.
The firm said it expects to begin trials of the two-dose vaccine in December and if it…
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
Business19 hours agoSolid superannuation gains continue to roll in